-
Growth Hormone Treatment Improves Social Impairments in Patients with Genetic Disorder Known to Cause Autism
A growth hormone treatment can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published today on Pub Med, a public...
-
Mount Sinai Researchers Receive NIH Grant to Study Promising Treatment for Autism Subtype
Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS). The grant...
